Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank

By afschroeder • July 2, 2026

Kim HS, Rezaee-Zavareh MS, Wang Y, Attia AM, Kwak M, Burm S, Celtik D, Legaspi D, Khattab O, Kim N, Mengistu BM, Larios KN, Kim DS, Ayoub W, Kuo A, Martin P, Vipani A, Wang Y, Liangpunsakul S, Li D, Lu SC, Pandol S, Yang JD. Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank. Clin Gastroenterol Hepatol. 2026 Jul 1:S1542-3565(26)00404-0. doi: 10.1016/j.cgh.2026.04.035. Epub ahead of print. PMID: 42385787.

Tags: Cedars Sinai DoM, Cirrhosis, Coffee Consumption, Digestive Diseases, Hepatocellular carcinoma, Liver disease, Publications, UK Biobank

Disparities in Health Care Seeking and Physician Diagnosis of Irritable Bowel Syndrome: Results From a United States Survey

Almario CV, Liu J, Higgins C, Yerneni N, Boules M, Chey WD, Chang L. Disparities in Health Care Seeking and Physician Diagnosis of Irritable Bowel[...]

Longitudinal Study on the Influence of Physical Activity in Managing Fatigue in Patients With Colorectal Cancer

Liu L, Kazemian E, Loroña NC, Shirazipour C, Gong J, Crowder SL, Nguyen N, Damerell V, Mooney K, Playdon MC, Ulrich CM, Li CI, Shibata[...]

Artificial intelligence-derived splenic response in cardiac positron emission tomography is associated with major adverse cardiovascular events: a multi-site study

Ramirez G, Dharmavaram NL, Shanbhag A, Miller RJH, Kavanagh PB, Yi J, Lemley M, Builoff V, Marcinkiewicz A, Dey D, Hainer J, Wopperer S, Knight[...]